FDA withdraws approval of generic antidepressant
from Medscape News (free subscription)
The antidepressant Budeprion XL 300 mg, one of the generic formulations of extended-release bupropion hydrochloride, is not therapeutically equivalent to Wellbutrin XL 300 mg, the brand-name extended-release formulation, and will be removed from the market by the drug's manufacturers, according to an update from the Food and Drug Administration. Budeprion XL 300 mg is manufactured by Impax Laboratories and is marketed by Teva Pharmaceuticals USA.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063